EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person

Lenka Koklesova, Alena Mazurakova, Marek Samec, Kamil Biringer, Samson Mathews Samuel, Dietrich Büsselberg, Peter Kubatka, Olga Golubnitschaja

EPMA Journal · 2021-12 · 12 (4) · 477-505

DOI: 10.1007/s13167-021-00263-0 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift EPMA Journal, online erschienen am 11.11.2021. Verfasst von Lenka Koklesova und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia. Die Arbeit wurde bisher 167-mal zitiert (Crossref) und nennt 237 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rheinische Friedrich-Wilhelms-Universität Bonn.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Homocysteine (Hcy) metabolism is crucial for regulating methionine availability, protein homeostasis, and DNA-methylation presenting, therefore, key pathways in post-genomic and epigenetic regulation mechanisms. Consequently, impaired Hcy metabolism leading to elevated concentrations of Hcy in the blood plasma (hyperhomocysteinemia) is linked to the overproduction of free radicals, induced oxidative stress, mitochondrial impairments, systemic inflammation and increased risks of eye disorders, coronary artery diseases, atherosclerosis, myocardial infarction, ischemic stroke, thrombotic events, cancer development and progression, osteoporosis, neurodegenerative disorders, pregnancy complications, delayed healing processes, and poor COVID-19 outcomes, among others. This review focuses on the homocysteine metabolism impairments relevant for various pathological conditions. Innovative strategies in the framework of 3P medicine consider Hcy metabolic pathways as the specific target for in vitro diagnostics, predictive medical approaches, cost-effective preventive measures, and optimized treatments tailored to the individualized patient profiles in primary, secondary, and tertiary care.

Schlagwörter

Stichwörter der Autor:innen

Amino acidsBlood plasmaCOVID-19CancersCardiovascular riskCellular senescenceCoronary artery diseaseDNA methylationDiagnostic and treatment targetsDietary habitsEndothelial dysfunctionEpigeneticsEye disorderFolateGenetics

Autor:innen und Institutionen

  • Clinic of Obstetrics and Gynecology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
  • Jessenius Faculty of Medicine in Martin, Biomedical Centre Martin, Comenius University in Bratislava, Mala Hora 4D, 036 01 Martin, Slovakia.
  • Department of Physiology and Biophysics, Weill Cornell Medicine in Qatar, Education City, Qatar Foundation, 24144 Doha, Qatar.
  • Department of Medical Biology, Jessenius Faculty of Medicine, Comenius University in Bratislava, 036 01 Martin, Slovakia.
  • Predictive, Preventive, Personalised (3P) Medicine, Department of Radiation Oncology, University Hospital Bonn, Rheinische Friedrich-Wilhelms-Universität Bonn, 53127 Bonn, Germany.

Förderung

  • Rheinische Friedrich-Wilhelms-Universität Bonn

Zitieren

APA

Koklesova, L., Mazurakova, A., Samec, M., Biringer, K., Samuel, S. M., Büsselberg, D., Kubatka, P., & Golubnitschaja, O. (2021). Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA Journal, 12(4), 477-505. https://doi.org/10.1007/s13167-021-00263-0

Vancouver

Koklesova L, Mazurakova A, Samec M, Biringer K, Samuel SM, Büsselberg D, et al. Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person. EPMA Journal. 2021;12(4):477-505. doi:10.1007/s13167-021-00263-0

BibTeX
@article{Koklesova2021,
  author = {Koklesova, Lenka and Mazurakova, Alena and Samec, Marek and Biringer, Kamil and Samuel, Samson Mathews and Büsselberg, Dietrich and Kubatka, Peter and Golubnitschaja, Olga},
  title = {Homocysteine metabolism as the target for predictive medical approach, disease prevention, prognosis, and treatments tailored to the person},
  journal = {EPMA Journal},
  year = {2021},
  volume = {12},
  number = {4},
  pages = {477--505},
  doi = {10.1007/s13167-021-00263-0}
}
Kostenlos starten →